Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2025-12-25 @ 7:34 PM
Study NCT ID:
NCT05533632
Status:
COMPLETED
Last Update Posted:
2025-09-24
First Post:
2022-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NN9535-4844
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None